Crossmark

Patient Frailty Should Be Used to Individualize Treatment Decisions in Primary Hyperparathyroidism

Crossref DOI link: https://doi.org/10.1007/s00268-018-4629-3

Published Online: 2018-04-25

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Seib, Carolyn D.

Chomsky‐Higgins, Kathryn

Gosnell, Jessica E.

Shen, Wen T.

Suh, Insoo

Duh, Quan‐Yang

Finlayson, Emily
Funding

Funding for this research was provided by:

National Institute on Aging (P30 AG44281, R01 AG044425, R21 AG054208)

Patient-Centered Outcomes Research Institute (1502‐27462)

National Institute on Aging (P30 AG44281, R01 AG044425, R21 AG054208)

Patient-Centered Outcomes Research Institute (1502-27462)
License Information

Version of Record valid from 2018-04-25

Text and Data Mining valid from 2018-04-25

Version of Record valid from 2018-04-25
More Information

Article History

First Online: 25 April 2018

Compliance with ethical standards

:

: Dr. Finlayson is a founder’s shareholder in Ooney, Inc. No other conflicts were reported.